1 completed, 1 unknown. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Yang I. Pachankis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID-19 Vaccination Detoxification in LDL-C Atorvastatin Calcium Tablets - COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction | Phase 1 | Unknown | Yang I. Pachankis | 1 | 2023-05-01 | 2023-05-06 |
| Medicine-induced Cardiac Hemodialysis on COVID-19 Nifedipine 30 MG, Kangzhu BPCB0A-3A, Low Mobility - Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis | Phase 4 | Completed | Yang I. Pachankis | 1 | 2023-01-02 | 2023-02-03 |
COVID-19 (1) · COVID-19 post-intensive care syndrome (1) · COVID-19 stress syndrome (1) · Immunologic Deficiency Syndromes (1) · Severe Acute Respiratory Syndrome (1) · Virus Diseases (1)
Atorvastatin (1) · Capsules (1) · Docosahexaenoic Acids (1) · Duloxetine Hydrochloride (1) · Enalapril (1) · Lansoprazole (1) · Metoprolol (1) · Nifedipine (1) · Superoxide Dismutase (1) · alpha-Tocopherol (1) · coenzyme Q10 (1) · low mobility group protein 160, rat (1)
China (2)